Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Nadolol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 5 USDMF, 2 CEP/COS, 1 JDMF, 3 EU WC, 7 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 52 FDA Orange Book, 4 Europe, 5 Canada, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 17 SPI Pharma, 3 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 15 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 7 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders, 38 Coating Systems & Additives, 37 Direct Compression, 31 Granulation, 31 Disintegrants & Superdisintegrants, 19 Taste Masking, 19 Controlled & Modified Release, 18 Thickeners and Stabilizers, 18 Chewable & Orodispersible Aids, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 10 Solubilizers, 8 Parenteral, 5 Rheology Modifiers, 5 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 17 Regulatory FDF Prices

MARKET PLACE

1 APIs

1 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	Biophore India Pharmaceuticals Pvt Ltd	India	BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad IN	CEP 2017-209 - Rev 02	Nadolol	2024-07-16	Valid	Chemical		1789
31/10/2025	Matrix Pharmaceutical Inc	U.S.A	MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN	CEP 2009-372 - Rev 05	Nadolol	2025-09-16	Valid	Chemical		1789

Nadolol

Nadolol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

5 USDMF

2 CEP/COS

1 JDMF

3 EU WC

7 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers

52 FDA Orange Book

4 Europe

5 Canada

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG

TABLET;ORAL - 40MG

TABLET;ORAL - 80MG

TABLET;ORAL - 5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

17 SPI Pharma

3 DKSH

5 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Kirsch Pharma

1 ACG Worldwide

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

15 BASF

1 CD Formulation

10 Corel Pharma Chem

7 DFE Pharma

7 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

7 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders

38 Coating Systems & Additives

37 Direct Compression

31 Granulation

31 Disintegrants & Superdisintegrants

TABLET;ORAL - 5MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons